Literature DB >> 33589729

Temporal and seasonal variations in incidence of stage II and III NEC-a 28-year epidemiologic study from tertiary NICUs in Connecticut, USA.

Darius Javidi1, Zigeng Wang2, Sanguthevar Rajasekaran2, Naveed Hussain3.   

Abstract

OBJECTIVE: To investigate seasonality and temporal trends in the incidence of NEC. STUDY
DESIGN: A retrospective cohort study from two tertiary NICUs in northern and central Connecticut involving 16,761 infants admitted over a 28-year period. Various perinatal and neonatal risk factors were evaluated by univariate, multivariate, and spectral density analyses.
RESULTS: Incidence of NEC was unchanged over the 28 years of study. Gestational age, birth weight, and birth-months (birth in April/May) were independently associated with stage II or III NEC even after adjusting for confounding factors (p < 0.05). Yearly NEC incidence showed a multi-modal distribution with spectral density spikes approximately every 10 years. CONCLUSION(S): Temporal and seasonal factors may play a role in NEC with a peak incidence in infants born in April/May and periodicity spikes approximately every 10 years. These trends suggest non-random and possibly environmental factors influencing NEC.

Entities:  

Year:  2021        PMID: 33589729     DOI: 10.1038/s41372-021-00961-7

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  50 in total

1.  Frequency of and risk factors for necrotizing enterocolitis in infants born before 33 weeks of gestation.

Authors:  M Hällström; A M Koivisto; M Janas; O Tammela
Journal:  Acta Paediatr       Date:  2003       Impact factor: 2.299

2.  NECROTIZING ENTEROCOLITIS IN THE PREMATURE INFANT.

Authors:  W E BERDON; H GROSSMAN; D H BAKER; A MIZRAHI; O BARLOW; W A BLANC
Journal:  Radiology       Date:  1964-11       Impact factor: 11.105

Review 3.  [Necrotizing enterocolitis (nec): risk factors and genetic susceptibility].

Authors:  M Somaschini; A Breda-Klobus; I Pacati
Journal:  Minerva Pediatr       Date:  2012-02       Impact factor: 1.312

Review 4.  A critical question for NEC researchers: Can we create a consensus definition of NEC that facilitates research progress?

Authors:  Phillip V Gordon; Jonathan R Swanson; Brianna C MacQueen; Robert D Christensen
Journal:  Semin Perinatol       Date:  2016-11-17       Impact factor: 3.300

5.  Mortality and intestinal failure in surgical necrotizing enterocolitis.

Authors:  John Kelleher; Himel Mallick; Thomas D Soltau; Carroll M Harmon; Reed A Dimmitt
Journal:  J Pediatr Surg       Date:  2013-03       Impact factor: 2.545

Review 6.  New Medical and Surgical Insights Into Neonatal Necrotizing Enterocolitis: A Review.

Authors:  Brandy L Frost; Biren P Modi; Tom Jaksic; Michael S Caplan
Journal:  JAMA Pediatr       Date:  2017-01-01       Impact factor: 16.193

7.  Risk factors for necrotizing enterocolitis in preterm infants: how race, gender, and health status contribute.

Authors:  Brigit M Carter; Diane Holditch-Davis
Journal:  Adv Neonatal Care       Date:  2008-10       Impact factor: 1.968

8.  Epidemiologic and bacteriologic evaluation of neonatal necrotizing enterocolitis.

Authors:  M J Bell; P Shackelford; R D Feigin; J L Ternberg; T Brotherton
Journal:  J Pediatr Surg       Date:  1979-02       Impact factor: 2.545

9.  Feeding practices and other risk factors for developing transfusion-associated necrotizing enterocolitis.

Authors:  Chris Derienzo; P Brian Smith; David Tanaka; Nicholas Bandarenko; Mary Lee Campbell; Annadele Herman; Ronald N Goldberg; C Michael Cotten
Journal:  Early Hum Dev       Date:  2014-03-02       Impact factor: 2.079

10.  [Risk factors of necrotizing enterocolitis].

Authors:  C A Tapia-Rombo; M R Velasco-Lavín; A Nieto-Caldelas
Journal:  Bol Med Hosp Infant Mex       Date:  1993-09
View more
  1 in total

Review 1.  Spontaneous intestinal perforation (SIP) will soon become the most common form of surgical bowel disease in the extremely low birth weight (ELBW) infant.

Authors:  Jonathan R Swanson; Amy Hair; Reese H Clark; Phillip V Gordon
Journal:  J Perinatol       Date:  2022-02-17       Impact factor: 2.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.